Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» RSV
RSV
Novavax still plans to push RSV vaccine to market after failed trial
Bizjournals
Tue, 06/11/19 - 09:41 am
Novavax
RSV
clinical trials
vaccines
ResVax
J&J mops up $900M in waste, writing off the last big chunk of the $1.75B it spent to acquire Alios
Endpoints
Thu, 03/21/19 - 11:09 pm
JNJ
Alios
RSV
Can Novavax Convince the FDA Its Vaccine Deserves a Chance?
Motley Fool
Fri, 03/1/19 - 11:54 pm
Novavax
RSV
vaccines
FDA
clinical trials
Another PhIII RSV failure thumps beleaguered Novavax, but execs claim there's a way forward
Endpoints
Thu, 02/28/19 - 10:04 am
RSV
vaccines
Novavax
clinical trials
AZ’s lung drug gets fast development in EU and US
Pharmaforum
Tue, 02/5/19 - 09:49 am
AstraZeneca
MEDI8897
RSV
Europe
fast track
AstraZeneca makes $1B-plus in cash-and-stock deal granting Sobi US rights to RSV drug Synagis
Endpoints
Tue, 11/13/18 - 10:29 am
AstraZeneca
Sobi
Synagis
RSV
J&J takes $630M hit on RSV drug bought with Alios
Fierce Biotech
Thu, 10/18/18 - 11:22 am
JNJ
RSV
Alios BioPharma
AL-8176
lumicitabine
ReViral Completes $55 Million Series B Round to Advance RSV Treatment
CP Wire
Wed, 08/1/18 - 10:45 am
ReViral
RSV
RV521
Pfizer Begins a Phase 1/2 Study to Evaluate RSV Vaccine
CP Wire
Tue, 05/22/18 - 11:27 am
Pfizer
vaccines
RSV
clinical trials
RSV Vaccine
Pfizer Begins a Phase 1/2 Study to Evaluate RSV Vaccine
Tue, 05/22/18 - 08:30 am
Pfizer
RSV
RSV Vaccine
vaccines
Ph III Study of Infant via Maternal Immunization Vaccine for RSV Reaches Milestone
CP Wire
Mon, 05/7/18 - 05:24 pm
Novavax
RSV
vaccines
RSV F vaccine
infant via maternal immunization
JPM18: Novavax investors cheer RSV vaccine update, then pull back
Biopharma Dive
Thu, 01/11/18 - 11:49 pm
Novavax
vaccines
RSV
JPMHC 2018
In a rare misfire, Regeneron scraps its RSV drug after a PhIII failure
Endpoints
Mon, 08/14/17 - 09:36 pm
Regeneron
RSV
clinical trials
REGN2222
suptavumab
Novavax makes a case for a do-over on its failed RSV vaccine — but it’s an uphill climb
Endpoints
Tue, 07/25/17 - 12:02 am
Novavax
vaccines
RSV
RSV F vaccine
Eyeing a $6B market, Bavarian Nordic posts positive phase 2 data for universal RSV vaccine
Fierce Pharma
Wed, 06/28/17 - 09:22 am
Bavarian Nordic
clinical trials
vaccines
RSV
Sanofi steps up with a $645M deal to partner with AstraZeneca on a late-stage RSV antibody
Endpoints
Fri, 03/3/17 - 09:24 am
Sanofi
AstraZeneca
RSV
MEDI8897
Novavax aims to rebound with restructuring, more trials
BioPharma Dive
Mon, 11/14/16 - 11:18 am
Novavax
restructuring
clinical trials
RSV
How the Zika virus could be a major bright spot for Novavax
Bizjournals.com
Sun, 11/13/16 - 11:52 am
Zika virus
Novavax
vaccines
RSV
Novavax cuts jobs to push ahead with respiratory vaccine for elderly
Yahoo/Reuters
Thu, 11/10/16 - 10:25 am
Novavax
layoffs
vaccines
RSV
Novavax's Big Disappointment -- What's Next?
Motley Fool
Mon, 10/3/16 - 09:55 am
Novavax
vaccines
RSV
RSV-F
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
next ›
last »